Chemours' Reduced Litigation Risk Removes Susquehanna's Objections To The Stock

Susquehanna upgraded Chemours Co CC to Positive from Neutral on reduced litigation risk, improved TiO2 prices and potential upside to 2017 EBITDA outlook.

On Monday, E I Du Pont De Nemours And Co DD and Chemours announced a global settlement of the multi-district PFOA litigation between DuPont and the plaintiffs. Under the settlement, subject to approval by the plaintiffs, DuPont and Chemours will each pay $335.35 million.

Susquehanna Weighs In

Analyst Don Carson noted that Chemours's portion of the cost is nearly 40 percent lower than Susquehanna’s base-case $550 million estimate.

Related Link: The Sectors Hedge Funds Are Most Bullish And Bearish On To Start 2017

In addition, the average TiO2 pricing in 2016 increased for the first time since 2012. Carson expects $0.05/lb of Chemours's $0.06/lb first quarter price increase to be realized in February due to the unplanned outage at Huntsman's facility in Europe and strong order books.

“Chemours is well positioned to benefit from the cyclical recovery of TiO2 pricing that is still in early innings as well as faster adoption of Opteon refrigerant due to EU regulatory requirements and voluntary U.S. adoption,” Carson wrote in a note.

Notably, faster Opteon adoption would increase Fluoro products earnings, while Chemours’ margins should benefit from an incremental $150 million of cost savings slated for 2017.

Stock Movement, Now And Ahead

However, despite the earnings beat, shares fell more than 2 percent on Thursday due to 2017 EBITDA guidance of greater than $1 billion that was more modest than investors expected.

But, Carson believes the pullback creates a buying opportunity as he sees significant upside to the EBITDA forecast given greater than expected momentum in TiO2 prices.

In fact, Carson raised his 2017 EBITDA estimate to $1.250 billion and EPS view to $3.00 (prior $960 million and $1.90). The analyst also raised the price target on the shares to $40 from $26.

At last check, shares of Chemours rose 4.23 percent to $33.25.

Image Credit: By Snoopywv - Own work, CC BY-SA 3.0, via Wikimedia Commons
Posted In: Don CarsonSusquehannaAnalyst ColorLong IdeasNewsUpgradesPrice TargetLegalAnalyst RatingsMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.